Beacon Pointe Advisors »

Bioxcel Therapeutics shares owned by Beacon Pointe Advisors

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Beacon Pointe Advisors from 13F filings

Historical chart of Beacon Pointe Advisors investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Beacon Pointe Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Beacon Pointe Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $25k 19k 1.34
2025-06-30 $34k 19k 1.81
2025-03-31 $38k 19k 2.03

More positions owned by Beacon Pointe Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Lennox International (LII)

View all positions for Beacon Pointe Advisors

Top funds holding Bioxcel Therapeutics

Millennium Management
Armistice Capital
Oaktree Capital Management
Geode Capital Management
Vanguard Capital Management
Jones Financial Companies, L.L
Man Group
State Street Corporation
FMR
Vanguard Fiduciary Trust
BlackRock
Wiley Bros.-aintree Capital
UBS Group
Oaktree Fund Advisors
HighTower Advisors

View all funds holding Bioxcel Therapeutics